These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22093541)

  • 1. Adherence to lipid-lowering agents.
    Ege MR; Yucel O; Acikgoz S
    Int J Clin Pract; 2011 Dec; 65(12):1321. PubMed ID: 22093541
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.
    Wong MC; Wang HH; Liu KS
    Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence, factors influencing and knowledge about adherence to lipid-lowering therapy among hyperlipidemia patients.
    Devaraj NK; Mohamed M; Hussein N
    Med J Malaysia; 2017 Jun; 72(3):157-164. PubMed ID: 28733563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to lipid-lowering agents among 11,042 patients in clinical practice.
    Wong MC; Jiang JY; Griffiths SM
    Int J Clin Pract; 2011 Jul; 65(7):741-8. PubMed ID: 21676117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*.
    Chapman RH; Ferrufino CP; Kowal SL; Classi P; Roberts CS
    Int J Clin Pract; 2010 Jan; 64(2):169-81. PubMed ID: 20089007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition probabilities and predictors of adherence in a California Medicaid population using antihypertensive and lipid-lowering medications.
    Nichol MB; Knight TK; Wu J; Tang SS; Cherry SB; Benner JS; Hussein M
    Value Health; 2009 Jun; 12(4):544-50. PubMed ID: 19138308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adherence to antihypertensive and lipid-lowering medications: a problem of public health, not yet resolved].
    Grosso G; Raciti T; Marventano S; Romeo I; Mistretta A
    Ann Ig; 2011; 23(2):173-84. PubMed ID: 21770233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Countering clinical inertia in lipid management: Expert workshop summary.
    Zullig LL; Egbuonu-Davis L; Trasy A; Oshotse C; Goldstein KM; Bosworth HB
    Am Heart J; 2018 Dec; 206():24-29. PubMed ID: 30290290
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
    Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting.
    Stacy JN; Schwartz SM; Ershoff D; Shreve MS
    Popul Health Manag; 2009 Oct; 12(5):241-54. PubMed ID: 19848566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current developments in lipid-lowering treatments].
    Krempf M
    Ann Endocrinol (Paris); 2005 Feb; 66(1):39-40. PubMed ID: 15798592
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipid-lowering therapy--from the '80s to the '90s. International symposium, Berlin, 19 September 1992].
    Internist (Berl); 1993 Feb; 34(2 Suppl):1-15. PubMed ID: 7591606
    [No Abstract]   [Full Text] [Related]  

  • 13. Adherence to lipid-lowering drug therapy among members of the Canadian Forces.
    Ma J; Vaillancourt R; Bennett C
    Mil Med; 2008 Jul; 173(7):666-70. PubMed ID: 18700601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid lowering drugs.
    O'Connor P; Feely J; Shepherd J
    BMJ; 1990 Mar; 300(6725):667-72. PubMed ID: 2182155
    [No Abstract]   [Full Text] [Related]  

  • 15. Barriers in utilizing lipid-lowering agents in non-institutionalized population in the U.S.: Application of a theoretical framework.
    Alfaifi AA; Lai L; Althemery AU
    PLoS One; 2021; 16(8):e0255729. PubMed ID: 34352007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of lipid-lowering medication in patients with acute myocardial infarction (Worcester Heart Attack Study).
    Goldberg RJ; Ockene IS; Yarzebski J; Savageau J; Gore JM
    Am J Cardiol; 1997 Apr; 79(8):1095-7. PubMed ID: 9114770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Getting the skinny on lipid-lowering drugs.
    Kuncl N; Nelson KM
    Nursing; 2000 Jul; 30(7):52-3. PubMed ID: 10983101
    [No Abstract]   [Full Text] [Related]  

  • 18. How can adherence to lipid-lowering medication be improved? A systematic review of randomized controlled trials.
    Schedlbauer A; Schroeder K; Fahey T
    Fam Pract; 2007 Sep; 24(4):380-7. PubMed ID: 17630270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to antihyperlipidemic medication and lipid control in diabetic Veterans Affairs patients with psychotic disorders.
    Nelson LA; Graham MR; Lindsey CC; Rasu RS
    Psychosomatics; 2011; 52(4):310-8. PubMed ID: 21777713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative therapy use and adherence to antihyperlipidemic drugs in a lipid clinic.
    O'Donnell DC; Brown CM; Piziak VK
    Am J Health Syst Pharm; 2001 Jun; 58(11):1017-21. PubMed ID: 11402475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.